间歇扫描式持续葡萄糖监测在胰岛素治疗2型糖尿病中的实施与住院及医疗费用变化
该研究评估了在胰岛素治疗的2型糖尿病成人中全面实施间歇扫描式持续葡萄糖监测(isCGM)对住院率、住院时长和住院费用的影响。结果显示,isCGM启动后糖尿病相关住院率显著下降,住院时长缩短,总住院费用降低,但心血管住院率保持稳定,其趋势在isCGM启动后相对于干预前趋势发生变化。
要点
- isCGM实施与糖尿病相关住院率显著下降相关(RR 0.37)。
- isCGM实施与住院时长中位数缩短(从4天降至3天)相关。
- isCGM实施与总住院费用降低相关,但心血管住院率保持稳定。
核心结论
- 在真实世界中,对胰岛素治疗的2型糖尿病成人实施isCGM与急性糖尿病相关住院大幅减少、住院时间缩短、医疗费用降低及心血管住院趋势改变相关。
主要发现
- 平均HbA1c从8.09%降至7.65%(平均差-0.44% [95%CI -0.47至-0.42])。
- 糖尿病相关住院率从74.6降至27.5每万人年(RR 0.37 [95%CI 0.28-0.49])。
- 心血管住院率保持稳定(228.8 vs. 215.8每万人年;RR 0.94 [95%CI 0.84-1.06])。
- 住院时长中位数从4天(四分位距5)降至3天(四分位距4)。
- 总住院费用减少3,806,776.90美元(每万人年减少955,186.70美元)。
临床怎么用
- 对于每日多次胰岛素注射的2型糖尿病成人,实施isCGM可能有助于减少急性糖尿病相关住院、缩短住院时间并降低医疗费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the effect of a population-wide implementation of intermittently scanned continuous glucose monitoring (isCGM) on hospitalization rates and trends, length of stay, and inpatient health care costs among adults with insulin-treated type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: This population-based, longitudinal, quasi-experimental cohort study included adults with T2D taking multiple daily insulin injections who initiated publicly funded isCGM between April 2022 and December 2023. Hospitalizations for acute diabetes-related complications (diabetic ketoacidosis, hyperglycemic hyperosmolar state, simple hyperglycemia, and hypoglycemia) and cardiovascular complications (myocardial infarction, stroke, and major lower-extremity amputation) were identified using ICD-10 codes. Incidence rates and rate ratios (RRs) were estimated using Poisson models. Interrupted time series analyses were used to estimate counterfactual trends. RESULTS: Among 15,413 participants, the mean follow-up was 22.5 ± 4.6 months before and 19.1 ± 4.4 months after isCGM initiation. Mean HbA1c decreased from 8.09 to 7.65% (mean difference -0.44 [95% CI -0.47 to -0.42]). Diabetes-related hospitalization rates decreased from 74.6 to 27.5 per 10,000 person-years (RR 0.37 [95% CI 0.28-0.49]). Cardiovascular hospitalization rates remained stable (228.8 vs. 215.8 per 10,000 person-years; RR 0.94 [0.84-1.06]). Interrupted time series analyses showed a change in cardiovascular admission rates after isCGM initiation relative to the preintervention trend. Median length of stay decreased from 4 (interquartile range 5) to 3 (4) days. Total inpatient costs decreased by $3,806,776.90 (-$955,186.70 per 10,000 person-years). CONCLUSIONS: In this real-world study, implementation of isCGM among insulin-treated adults with T2D was associated with substantial reductions in acute diabetes-related hospitalizations, shorter hospital stays, lower health care costs, and changes in cardiovascular hospitalization trends.
引用
- Rodríguez de Vera Gómez P, Mayoral E, Rodríguez Jiménez B, et al. Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes. Diabetes Care. 2026. PMID: 42301188. doi:10.2337/dc26-0547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。